The ET patient with the IDH2 R140Q mutation harbored JAK2V617F mutation with an allele burden of 5% while the other patient with IDH1 R132C mutation did not harbor JAK2V617F mutation. This evidence concerns the gene IDH2 and essential thrombocythemia.